554 related articles for article (PubMed ID: 27469262)
1. The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma.
Sload R; Silver N; Jawad BA; Gross ND
Curr Oncol Rep; 2016 Sep; 18(9):53. PubMed ID: 27469262
[TBL] [Abstract][Full Text] [Related]
2. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ
Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634
[TBL] [Abstract][Full Text] [Related]
3. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status.
Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265
[TBL] [Abstract][Full Text] [Related]
4. The Role of Surgery in the Management of Recurrent Oropharyngeal Cancer.
Gross ND; Hanna EY
Recent Results Cancer Res; 2017; 206():197-205. PubMed ID: 27699540
[TBL] [Abstract][Full Text] [Related]
5. Transoral robotic surgery for oropharyngeal squamous cell carcinoma.
Schmitt NC; Duvvuri U
Curr Opin Otolaryngol Head Neck Surg; 2015 Apr; 23(2):127-31. PubMed ID: 25692632
[TBL] [Abstract][Full Text] [Related]
6. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
[TBL] [Abstract][Full Text] [Related]
7. Decision management in transoral robotic surgery: Indications, individual patient selection, and role in the multidisciplinary treatment for head and neck cancer from a European perspective.
Lörincz BB; Jowett N; Knecht R
Head Neck; 2016 Apr; 38 Suppl 1():E2190-6. PubMed ID: 25833809
[TBL] [Abstract][Full Text] [Related]
8. Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
Chillakuru Y; Benito DA; Strum D; Mehta V; Saini P; Shim T; Darwish C; Joshi AS; Thakkar P; Goodman JF
Head Neck; 2021 Jul; 43(7):2259-2273. PubMed ID: 33899949
[TBL] [Abstract][Full Text] [Related]
9. Current Indications for Transoral Robotic Surgery in Oropharyngeal Cancer.
Parhar HS; Yver CM; Brody RM
Otolaryngol Clin North Am; 2020 Dec; 53(6):949-964. PubMed ID: 32912662
[TBL] [Abstract][Full Text] [Related]
10. Open Versus Robotic Surgery for Oropharyngeal Cancer.
Jefferson GD; Frey H
Otolaryngol Clin North Am; 2020 Dec; 53(6):995-1003. PubMed ID: 32854946
[TBL] [Abstract][Full Text] [Related]
11. The role of transoral robotic surgery in the management of oropharyngeal squamous cell carcinoma: a current review.
Sansoni ER; Gross ND
Curr Oncol Rep; 2015 Mar; 17(3):432. PubMed ID: 25687805
[TBL] [Abstract][Full Text] [Related]
12. A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx.
Swisher-McClure S; Lukens JN; Aggarwal C; Ahn P; Basu D; Bauml JM; Brody R; Chalian A; Cohen RB; Fotouhi-Ghiam A; Geiger G; Gershowitz J; Livolsi V; Mitra N; Montone K; Newman J; Ojerholm E; O'Malley B; Rajasekaran K; Tan E; Weinstein G; Lin A
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):725-732. PubMed ID: 31785337
[TBL] [Abstract][Full Text] [Related]
13. Surgical Options for Locally Advanced Oropharyngeal Cancer.
Qureshi HA; Abouyared M; Barber B; Houlton JJ
Curr Treat Options Oncol; 2019 Apr; 20(5):36. PubMed ID: 30931485
[TBL] [Abstract][Full Text] [Related]
14. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
[TBL] [Abstract][Full Text] [Related]
15. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
[TBL] [Abstract][Full Text] [Related]
16. Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
Mahmoud O; Sung K; Civantos FJ; Thomas GR; Samuels MA
Head Neck; 2018 Apr; 40(4):710-721. PubMed ID: 29244238
[TBL] [Abstract][Full Text] [Related]
17. Adoption of transoral robotic surgery compared with other surgical modalities for treatment of oropharyngeal squamous cell carcinoma.
Cracchiolo JR; Roman BR; Kutler DI; Kuhel WI; Cohen MA
J Surg Oncol; 2016 Sep; 114(4):405-11. PubMed ID: 27392812
[TBL] [Abstract][Full Text] [Related]
18. Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial.
Dabas S; Gupta K; Ranjan R; Sharma AK; Shukla H; Dinesh A
Oral Oncol; 2017 Jun; 69():80-83. PubMed ID: 28559025
[TBL] [Abstract][Full Text] [Related]
19. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U
Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606
[TBL] [Abstract][Full Text] [Related]
20. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]